Status:
WITHDRAWN
A Prospective Trial of COXEN Chemotherapy Prediction
Lead Sponsor:
University of Virginia
Conditions:
Ovarian Neoplasms
Fallopian Tube Neoplasms
Eligibility:
FEMALE
18-95 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if the COXEN algorithm, using the diagnostic device Affymetrix GeneChip, is able to predict which chemotherapies will be best for treatment of recurrent or pe...
Detailed Description
The current proposal seeks to apply and extend this novel genomic prediction technique to finding better chemotherapeutic options for recurrent ovarian cancer using individual patients' gene-expressio...
Eligibility Criteria
Inclusion
- age greater than 18
- diagnosis of recurrent, persistent, refractory ovarian, fallopian or primary peritoneal cancer
- tumor tissue, ascites or pleural fluid available for biopsy
- life expectancy greater than 6 months
Exclusion
- patients with borderline or low malignant histologies
- patients with a history of other malignancies within last 5 years
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01228942
Start Date
October 1 2010
End Date
June 1 2013
Last Update
June 6 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.